ASX Futures up 38 points following strong gains in Europe and the US

Published 29-SEP-2020 09:47 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

The S&P/ASX 200 index (XJO) slid 13 points to 5952 points on Monday, dragged lower by the big banks and constituents of the Consumer Staples index such as Woolworths (ASX:WOW) which has given up 2% in less than a week.

It was only a strong performance by the tech sector that limited the decline to modest levels.

Given the overnight surge in the NASDAQ, tech stocks could once again be in the spotlight today.

The ASX SPI200 index is up 38 points to 5932 points, suggesting we could see a significant bounce.

However, there were also strong performances from the other US indices, and especially, the UK and European region where the DAX gained a massive 402 points or 3.2% to close at 12,870 points.

Until last week, the DAX has slowly but steadily being shaking off the coronavirus blues, getting within a few hundred points of its early 2020 highs.

After giving up more than 600 points last week, last night’s gain has gone a long way to erasing those losses.

It was a similar story in France with the CAC 40 gaining 2.4% to close at 4843 points.

In the UK, the FTSE 100 rallied 1.5% or 85 points, closing at 5927 points.

Back to the US, it wasn’t just the NASDAQ that was in good form, both the Dow and the S&P 500 gained more than 1.5% with the former surging 410 points to close at 27,584 points.

The S&P 500 gained 53 points as it closed at 3351 points.

Gold rebounds, AUD supportive of Australian-based metal producers

Looking across the commodities, gold recovered some of its recent losses to close at US$1882 per ounce, and it was still on the up in aftermarket trading, hitting US$1888 per ounce.

As we highlighted yesterday, the decline in the Australian dollar against the US dollar absorbed around 50% of the decline in the gold price over the last week, and investors have latched onto this theme over the last two trading days with the S&P/ASX All Ordinaries Gold Index (XGD) surging 350 points or more than 4% despite a significant fall in the US dollar gold price.

This trend should continue despite a slight strengthening in the Australian dollar overnight as it is still hovering below US$0.71, having shed about 3% in the last fortnight.

Iron ore stocks could also receive support today following a moderate rebound to US$116 per tonne.

There was also a significant kick in the oil price with the Brent Crude Oil Continuous Contract surging from about US$42 per barrel in morning trading to touch on US$43 per barrel as markets drew to a close.

Base metals were mixed with copper coming off slightly to close just below US$2.98 per pound after recording its fifth consecutive day of declines.

Nickel was up slightly to US$6.53 per pound.

There was little movement in the lead price, while zinc was the standout performer, gaining about 1.8% to US$1.09 per pound.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X